Related references
Note: Only part of the references are listed.Variations in Core Packing of GP2 from Old World Mammarenaviruses in their Post-Fusion Conformations Affect Membrane-Fusion Efficiencies
Anastasiya Shulman et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Shuai Xia et al.
SCIENCE ADVANCES (2019)
Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains
Shuai Xia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors
Chao Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structural basis for antibody-mediated neutralization of Lassa virus
Kathryn M. Hastie et al.
SCIENCE (2017)
An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions
Qianqian Li et al.
VACCINE (2017)
HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions
Qianqian Qi et al.
EMERGING MICROBES & INFECTIONS (2017)
Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses
Xiaohuan Wang et al.
FRONTIERS OF MEDICINE (2017)
A novel HIV-1 gp41 tripartite model for rational design of HIV-1 fusion inhibitors with improved antiviral activity
Shan Su et al.
AIDS (2017)
Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis
Joel Oppliger et al.
JOURNAL OF VIROLOGY (2016)
Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike
Sai Li et al.
PLOS PATHOGENS (2016)
Rational improvement of gp41-targeting HIV-1 fusion inhibitors: an innovatively designed Ile-Asp-Leu tail with alternative conformations
Yun Zhu et al.
SCIENTIFIC REPORTS (2016)
Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection
Rudragouda Channappanavar et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide Strategy
Xiaojie Zhu et al.
SCIENTIFIC REPORTS (2015)
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu Lu et al.
NATURE COMMUNICATIONS (2014)
Lassa Fever in Post-Conflict Sierra Leone
Jeffrey G. Shaffer et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Lassa Fever in West Africa: Evidence for an Expanded Region of Endemicity
N. Sogoba et al.
ZOONOSES AND PUBLIC HEALTH (2012)
Molecular Diagnostics for Lassa Fever at Irrua Specialist Teaching Hospital, Nigeria: Lessons Learnt from Two Years of Laboratory Operation
Danny A. Asogun et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes
Emily Happy Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Characterization of Lassa Virus Cell Entry and Neutralization with Lassa Virus Pseudoparticles
Francois-Loic Cosset et al.
JOURNAL OF VIROLOGY (2009)
Different mechanisms of cell entry by human-pathogenic old world and New World arenaviruses
Jillian M. Rojek et al.
JOURNAL OF VIROLOGY (2008)
Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism
Eric M. Vela et al.
VIROLOGY (2007)
Solving structures of protein complexes by molecular replacement with Phaser
Airlie J. McCoy
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2007)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Share Paper
